Robuta

https://pubs.rsc.org/en/content/articlelanding/2021/sc/d1sc01494c Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors:... SARS-CoV-2, the cause of the COVID-19 pandemic, exploits host cell proteins for viral entry into human lung cells. One of them, the protease TMPRSS2, is... sars cov 2cellentrycovalentprotease https://www.nature.com/articles/s42003-020-01577-x?error=cookies_not_supported&code=d3b7151a-f5dd-43aa-b4d1-e6ecf7816f59 Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2... Jan 20, 2021 - Emerging outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is a major threat to public health. The morbidity is increasing due... sars cov 2identificationlikeproteaseinhibitors